EUVIMEDEUVIMED entdecken
QuerschnittstudieOpen Access · CC BY 4.0

Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of Mecp2 Heterozygous Mouse Females

Catarina Miranda-Lourenço iD, Jéssica Rosa, Nádia Rei iD, Rita F Belo iD, Ana Luísa Lopes, Diogo Silva, Cátia Vieira, Teresa Magalhães-Cardoso, Ricardo Viais, Paulo Correia-de-Sá iD, Ana M Sebastião, Maria J Diógenes

International Journal of Molecular Sciences · 2023

DOI: 10.3390/ijms242216249 ↗

Kurz gefasst

Querschnittstudie in der Zeitschrift International Journal of Molecular Sciences, 2023. Verfasst von Catarina Miranda-Lourenço und 11 weiteren Autor:innen. Beteiligte Einrichtung: Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal. Hauptthemen laut MEDLINE: Brain-Derived Neurotrophic Factor, Rett Syndrome. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 56 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fundação para a Ciência e Tecnologia, University of Lisbon, Association Française du Syndrome de Rett.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Rett Syndrome is an X-linked neurodevelopmental disorder (RTT; OMIM#312750) associated to MECP2 mutations. MeCP2 dysfunction is seen as one cause for the deficiencies found in brain-derived neurotrophic factor (BDNF) signaling, since BDNF is one of the genes under MeCP2 jurisdiction. BDNF signaling is also dependent on the proper function of the adenosinergic system. Indeed, both BDNF signaling and the adenosinergic system are altered in Mecp2-null mice (Mecp2−/y), a representative model of severe manifestation of RTT. Considering that symptoms severity largely differs among RTT patients, we set out to investigate the BDNF and ADO signaling modifications in Mecp2 heterozygous female mice (Mecp2+/−) presenting a less severe phenotype. Symptomatic Mecp2+/− mice have lower BDNF levels in the cortex and hippocampus. This is accompanied by a loss of BDNF-induced facilitation of hippocampal long-term potentiation (LTP), which could be restored upon selective activation of adenosine A2A receptors (A2AR). While no differences were observed in the amount of adenosine in the cortex and hippocampus of Mecp2+/− mice compared with healthy littermates, the density of the A1R and A2AR subtype receptors was, respectively, upregulated and downregulated in the hippocampus. Data suggest that significant changes in BDNF and adenosine signaling pathways are present in an RTT model with a milder disease phenotype: Mecp2+/− female animals. These features strengthen the theory that boosting adenosinergic activity may be a valid therapeutic strategy for RTT patients, regardless of their genetic penetrance.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Brain-Derived Neurotrophic FactorRett SyndromeAnimalsFemaleHumansMiceAdenosineCross-Sectional StudiesDisease Models, AnimalMethyl-CpG-Binding Protein 2Mice, Knockout

Stichwörter der Autor:innen

BDNFMecp2 heterozygous femalesRett syndromeadenosine

Substanzen

AdenosineBrain-Derived Neurotrophic FactorMecp2 protein, mouseMethyl-CpG-Binding Protein 2

Autor:innen und Institutionen

  • Instituto de Farmacologia e Neurociências, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
  • Instituto de Medicina Molecular João Lobo Antunes, Faculdade de Medicina, Universidade de Lisboa, 1649-028 Lisboa, Portugal.
  • Laboratório de Farmacologia e Neurobiologia/MedInUP, Instituto de Ciências Biomédicas Abel Salazar-Universidade do Porto (ICBAS-UP), 4050-313 Porto, Portugal.

ORCID-Profile: Catarina Miranda-Lourenço, Nádia Rei, Rita F Belo, Paulo Correia-de-Sá

Förderung

  • Fundação para a Ciência e Tecnologia
  • University of Lisbon
  • Association Française du Syndrome de Rett
  • Faculdade de Medicina da Universidade de Lisboa/CHLN
  • Twinnig action - Synanet
  • Universidade de Lisboa
  • Program “Educação pela Ciência”
  • Bolsas CHLN/FMUL—GAPIC

Zitieren

APA

Miranda-Lourenço, C., Rosa, J., Rei, N., Belo, R. F., Lopes, A. L., Silva, D., Vieira, C., Magalhães-Cardoso, T., Viais, R., Correia-de-Sá, P., Sebastião, A. M., & Diógenes, M. J. (2023). Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of Mecp2 Heterozygous Mouse Females. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms242216249

Vancouver

Miranda-Lourenço C, Rosa J, Rei N, Belo RF, Lopes AL, Silva D, et al. Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of Mecp2 Heterozygous Mouse Females. International Journal of Molecular Sciences. 2023. doi:10.3390/ijms242216249

BibTeX
@article{MirandaLoureno2023,
  author = {Miranda-Lourenço, Catarina and Rosa, Jéssica and Rei, Nádia and Belo, Rita F and Lopes, Ana Luísa and Silva, Diogo and Vieira, Cátia and Magalhães-Cardoso, Teresa and Viais, Ricardo and Correia-de-Sá, Paulo and Sebastião, Ana M and Diógenes, Maria J},
  title = {Adenosinergic System and BDNF Signaling Changes as a Cross-Sectional Feature of RTT: Characterization of Mecp2 Heterozygous Mouse Females},
  journal = {International Journal of Molecular Sciences},
  year = {2023},
  doi = {10.3390/ijms242216249}
}
Kostenlos starten →